Synapse

← Journal of Drug Assessment

Papers in Journal of Drug Assessment

Page 2 · newest first

  1. Phase 2, randomized, open-label study on catheter-directed thrombolysis with plasmin versus rtPA and placebo in acute peripheral arterial occlusionJournal of Drug Assessment · 2019
  2. Risk factors of mortality in patients with purple urine bag syndromeJournal of Drug Assessment · 2019
  3. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting ratesJournal of Drug Assessment · 2019
  4. Economic burden of relapse/recurrence in patients with major depressive disorderJournal of Drug Assessment · 2019
  5. Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)Journal of Drug Assessment · 2018
  6. Physician-community pharmacist collaborative care in diabetes management: a pilot studyJournal of Drug Assessment · 2018
  7. Role of point of care Hb diagnostic devices in getting the right picture of anemia control: Tangi Rural Anemia Diagnostic Accuracy StudyJournal of Drug Assessment · 2018
  8. Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinicJournal of Drug Assessment · 2018
  9. A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation studyJournal of Drug Assessment · 2018
  10. The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitusJournal of Drug Assessment · 2018
  11. A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteersJournal of Drug Assessment · 2018
  12. Systematic review and meta-analysis of the efficacy of liposomal bupivacaine in colorectal resectionsJournal of Drug Assessment · 2018
  13. Treatment patterns, clinical and economic outcomes of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer receiving ceritinib: a retrospective observational claims analysisJournal of Drug Assessment · 2018
  14. Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphomaJournal of Drug Assessment · 2017
  15. Evaluation of prokinetic agents used in the treatment of gastroparesisJournal of Drug Assessment · 2017
  16. Clinical presentation, epidemiology, neurophysiological findings, treatment and outcome of nonconvulsive status epilepticus: a 3-year prospective, hospital-based studyJournal of Drug Assessment · 2017
  17. Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trialJournal of Drug Assessment · 2016
  18. Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational studyJournal of Drug Assessment · 2016
  19. Off target effects of statins shape total mortality?Journal of Drug Assessment · 2016
  20. Predictors of long-term mortality in new start statin usersJournal of Drug Assessment · 2015
  21. Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteersJournal of Drug Assessment · 2015
  22. Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosisJournal of Drug Assessment · 2015
  23. Occurrence of drug–drug interactions in Adama Referral Hospital, Adama city, EthiopiaJournal of Drug Assessment · 2015
  24. Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic HirsutismJournal of Drug Assessment · 2015
  25. Absolute bioavailability and regional absorption of ticagrelor in healthy volunteersJournal of Drug Assessment · 2014
  26. Comparison of levocetirizine pharmacokinetics after single doses of levocetirizine oral solution and cetirizine dry syrup in healthy Japanese male subjectsJournal of Drug Assessment · 2014
  27. Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteersJournal of Drug Assessment · 2014
  28. Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a proof of concept analysisJournal of Drug Assessment · 2014
  29. A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorderJournal of Drug Assessment · 2014
  30. Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational studyJournal of Drug Assessment · 2014
  31. Impact of clinical pharmacist collaboration in patients beginning insulin pump therapy: a retrospective and cross-sectional analysisJournal of Drug Assessment · 2013
  32. Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileusJournal of Drug Assessment · 2013
  33. Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?Journal of Drug Assessment · 2013
  34. Pharmacokinetics, safety, and tolerability following single-dose migalastat hydrochloride (GR181413A/AT1001) in healthy male Japanese subjectsJournal of Drug Assessment · 2013
  35. Safety, tolerability, pharmacokinetics and pharmacodynamics of belimumab in Japanese patients with mild-to-moderate systemic lupus erythematosusJournal of Drug Assessment · 2013
  36. Effects of dalfampridine and its metabolites on cloned human potassium channels Kv1.1, Kv1.2, and Kv1.4 expressed in human embryonic kidney cellsJournal of Drug Assessment · 2013
  37. Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma – a pilot studyJournal of Drug Assessment · 2013
  38. Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteersJournal of Drug Assessment · 2013
  39. Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteersJournal of Drug Assessment · 2013
  40. Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donorsJournal of Drug Assessment · 2013
  41. Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrroniumJournal of Drug Assessment · 2013
  42. Aliskiren/amlodipine as a single-pill combination in hypertensive patients: subgroup analysis of elderly patients, with metabolic risk factors or high body mass indexJournal of Drug Assessment · 2012
  43. The role of the renin–angiotensin system blocking in the management of atrial fibrillationJournal of Drug Assessment · 2012
  44. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamberJournal of Drug Assessment · 2012
  45. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamberJournal of Drug Assessment · 2012
  46. Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertensionJournal of Drug Assessment · 2011